Related Articles
Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
Glypican-3 promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through ERK signaling pathway
High expression of RBM8A predicts poor patient prognosis and promotes tumor progression in hepatocellular carcinoma
Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway
Upregulation of the BDNF/TrKB pathway promotes epithelial-mesenchymal transition, as well as the migration and invasion of cervical cancer